caa a22 4500 445797800 CHVBK 20180317145131.0 cr unu---uuuuu 170323e20111101xx s 000 0 eng 10.1007/s10620-011-1840-6 doi (NATIONALLICENCE)springer-10.1007/s10620-011-1840-6 Barriers to Screening for Hepatitis B Virus Infection in Asian Americans [Elektronische Daten] [Ke-Qin Hu, Calvin Pan, Diane Goodwin] Background: Routine screening for hepatitis B virus (HBV) infection can identify individuals who need vaccination or treatment, as vaccination can prevent HBV infection. Although the overall prevalence of HBV infection in the United States is low (<1%), it is high (~10%) in Asian Americans. However, HBV screening rates in this population have been reported to be low. Aims: This article systemically reviews the reported prevalence of HBV infection, the rate of HBV screening and access to HBV care, barriers for HBV screening and care, and a possible approach for improving HBV screening in Asian Americans. Methods: Articles published from 1999 to 2011 on HBV screening and disparity in Asian Americans were identified by searching electronic databases (PubMed and Cochrane Library), and reviewed. Results: Published studies, including a recent report from the Institute of Medicine of the National Academies, revealed HBV screening rates are low in Asian Americans. This review addresses the need for HBV screening in Asian Americans. Barriers to HBV screening are related to patients, providers, and/or the healthcare system. Screening programs that incorporate culturally sensitive interventions and include educational outreach, vaccination, and a link to healthcare services improve rates of HBV screening and vaccination in this at-risk community. Conclusions: A strategy that integrates efforts from the healthcare profession, federal agencies, and the community will be needed to improve HBV screening and access to HBV care for Asian Americans. Springer Science+Business Media, LLC, 2011 Hepatitis B virus (HBV) nationallicence HBV infection nationallicence Chronic hepatitis B (CHB) nationallicence HBV vaccination nationallicence Cirrhosis nationallicence Hepatocellular carcinoma (HCC) nationallicence Asian Americans nationallicence Hu Ke-Qin Division of GI/Hepatology, University of California, Irvine, 101, The City Drive, Building 56, Rt. 81, Rm. 231, 92868, Orange, CA, USA aut Pan Calvin Division of Liver Diseases, Department of Medicine, The Mount Sinai Medical Center, Mount Sinai School of Medicine, New York, NY, USA aut Goodwin Diane Pharmacy Department, Duke University Hospital, Durham, NC, USA aut Digestive Diseases and Sciences Springer US; http://www.springer-ny.com 56/11(2011-11-01), 3163-3171 0163-2116 56:11<3163 2011 56 10620 https://doi.org/10.1007/s10620-011-1840-6 text/html Onlinezugriff via DOI 1 review-article jats NATIONALLICENCE 856 40 https://doi.org/10.1007/s10620-011-1840-6 text/html Onlinezugriff via DOI NATIONALLICENCE 700 1- Hu Ke-Qin Division of GI/Hepatology, University of California, Irvine, 101, The City Drive, Building 56, Rt. 81, Rm. 231, 92868, Orange, CA, USA aut NATIONALLICENCE 700 1- Pan Calvin Division of Liver Diseases, Department of Medicine, The Mount Sinai Medical Center, Mount Sinai School of Medicine, New York, NY, USA aut NATIONALLICENCE 700 1- Goodwin Diane Pharmacy Department, Duke University Hospital, Durham, NC, USA aut NATIONALLICENCE 773 0- Digestive Diseases and Sciences Springer US; http://www.springer-ny.com 56/11(2011-11-01), 3163-3171 0163-2116 56:11<3163 2011 56 10620 Metadata rights reserved Springer special CC-BY-NC licence nationallicence BK010053 XK010053 XK010000 NATIONALLICENCE NATIONALLICENCE NL-springer